Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity

NCT02576288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Inflammation

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

University of Southern California